COM:POXELPHARMA
Poxel SA
- Stock
locale
Francemarket
STOCKSindustry
Biotechnologywebsite
www.poxelpharma.comcrunchbase
poxellinkedin
poxelipo date
Feb 06, 2015
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is Imeglimin, an oral drug candidate, which completed Phase III clinical development stage in Japan, as well as in Phase III in the United States and Europe for the treatment of type 2 diabetes that improves pa...Show More